Patients and families should be educated about the disease and management. Understanding the daily activities and work environment of the patient will allow the clinician to help them in adjusting with the disease. Information about the local and national support groups should be provided as they can be a great resource to both patients and their families. Information about clinical trials should also be provided, and appropriate patients who are interested should be referred to as well.

There is no clear evidence that IBM affects life expectancy. However, loss of ambulation and dysphagia remain the main source of disability. Physical therapy, home-based exercise programs, assistive devices, and swallowing techniques are important considerations in improving the quality of life of the patients.